Results 21 to 30 of about 141,213 (164)
Statin Therapy and Symptom Burden in Patients With Fibromyalgia: A Prospective Questionnaire Study
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2021 Objective: To evaluate the association between statin use and symptom severity, tender point count, fatigue, cognition, mood, and sleep issues in patients with fibromyalgia (FM).
Ryan S. D’Souza, MD +2 more
doaj +1 more source
PLoS ONE, 2023 BackgroundAlthough statins are an effective strategy for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD) in the general population, the benefits for dialysis patients are controversial.
Myunhee Lee +5 more
doaj +1 more source
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
Journal of the Formosan Medical Association, 2019 Statin reduces low-density lipoprotein cholesterol and improves clinical outcomes in high risk patients. In general, statin is a safe and well-tolerated medication.
Shih-Chieh Chien +5 more
doaj +1 more source
Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature
Pharmacy, 2022 Statins are lipid-lowing medications shown to reduce cardiovascular events and are recommended for specific patient populations at elevated risk of atherosclerotic cardiovascular disease (ASCVD).
Mary Elkomos +2 more
doaj +1 more source
The pharmacogenomics of statins
Pharmacological Research, 2014 The statin class of cholesterol-lowering drugs have been used for decades to successfully lower plasma cholesterol concentrations and cardiovascular risk. Adverse effects of statins are generally considered mild, but increase with age of patients and polypharmacy.
Ingrid C, Gelissen, Andrew J, McLachlan
openaire +2 more sources
Utilization of Statins Beyond the Initial Period After Stroke and 1‐Year Risk of Recurrent Stroke
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017 BackgroundIn‐hospital discontinuation of statins has been linked to poorer early stroke outcomes, but the consequences of postdischarge discontinuation or dose reduction of statin treatment are unknown.
Meng Lee +10 more
doaj +1 more source
Methodist DeBakey Cardiovascular Journal, 2019 The discovery of statins (3-hydroxy-3-methylglutaryl CoA reductase inhibitors) is a consequence of the highly targeted, arduous search for naturally occurring compounds that inhibit cholesterol biosynthesis. An enormous amount of basic scientific, genetic, and clinical research substantiated the role of lipoprotein-derived cholesterol in atherogenesis.
Peter P, Toth, Maciej, Banach
openaire +2 more sources
Türk Kardiyoloji Derneği Arşivi, 2017 Objective: Lifelong statin treatment is recommended in patients with cardiovascular diseases, but drug adherence is a significant problem. The aim of this study was to investigate factors related to statin discontinuation in high-risk patients with ...
Tuba Özdemir +9 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground A study was designed to investigate whether the coronary artery disease polygenic risk score (CAD‐PRS) may guide lipid‐lowering treatment initiation as well as deferral in primary prevention beyond established clinical risk scores. Methods and
Hanjin Park +11 more
doaj +1 more source
Statin Use Among Women and Men Following Coronary Artery Bypass Surgery
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Limited data exist on sex differences in guideline‐recommended statin therapy for secondary prevention after coronary artery bypass surgery (CABG).
Sigrid Sandner +11 more
doaj +1 more source